Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephr
about
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsInteraction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivoInteraction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.Candida albicans endophthalmitis in a patient with a non-functioning pituitary adenoma evolving into Cushing׳s disease: A case report.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasisCombination treatment of invasive fungal infections.Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indolesImpact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone.A Case of Candida albicans Endophthalmitis with No Predisposing Risk Factors and a Distant Source of Infection.
P2860
Q30435365-FCC6B05A-2A1C-4799-BC6E-687E45670C00Q33803508-D2315F8F-4B40-4D64-8004-25F071A465F1Q33978197-D9A6F4CE-37DF-4C49-B742-8F560D496885Q34436162-E85E02B4-702B-4A89-8AFA-7A745AC2EF90Q34505582-CD00B78C-4176-457F-ADA6-4DEE3C8122DDQ35923224-7D8EE592-A81E-44D0-A938-CC258EED3074Q36011378-E2458451-F4D8-4F24-983A-7C561E73315CQ36068254-0AB1929A-9AAB-4743-961F-5BE4235C1788Q39476255-9960B155-CA0A-442E-8137-B8254EDED330Q42146510-05B35BA9-DB73-4FCE-AAA5-4C0A0309E68EQ42428437-B0F9C331-78D3-4789-9412-1BA72B81221F
P2860
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephr
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Efficacies of high-dose flucon ...... ndophthalmitis, and pyelonephr
@ast
Efficacies of high-dose flucon ...... ndophthalmitis, and pyelonephr
@en
type
label
Efficacies of high-dose flucon ...... ndophthalmitis, and pyelonephr
@ast
Efficacies of high-dose flucon ...... ndophthalmitis, and pyelonephr
@en
prefLabel
Efficacies of high-dose flucon ...... ndophthalmitis, and pyelonephr
@ast
Efficacies of high-dose flucon ...... ndophthalmitis, and pyelonephr
@en
P2093
P2860
P1476
Efficacies of high-dose flucon ...... ndophthalmitis, and pyelonephr
@en
P2093
D A Miller
G L Drusano
M H Miller
P2860
P304
P407
P577
1999-12-01T00:00:00Z